Invasive fungal infections are severe diseases caused by pathogenic fungi that penetrate and spread within the body, extending beyond the point of initial infection. These infections involve the penetration of fungal organisms into deeper layers of tissue, including the bloodstream, organs, or other body structures. The treatment of invasive fungal infections typically includes the use of antifungal medications and, in certain instances, surgical procedures to excise infected tissue.
The main types of invasive fungal infections encompass candidemia and invasive candidiasis, intraabdominal candidiasis, cryptococcal meningitis, esophageal candidiasis, histoplasmosis acute pulmonary, and others. Candidemia and invasive candidiasis, for instance, are infections caused by Candida fungus that can affect various parts of the body, including the blood, heart, brain, eyes, bones, or other organs. Treatment involves the use of different drug types, such as polyenes, triazoles, echinocandins, flucytosine, and others, and is administered by various end-users, including hospitals, homecare, specialty clinics, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The invasive fungal infections market research report is one of a series of new reports from The Business Research Company that provides invasive fungal infections market statistics, including invasive fungal infections industry global market size, regional shares, competitors with a invasive fungal infections market share, detailed invasive fungal infections market segments, market trends and opportunities, and any further data you may need to thrive in the invasive fungal infections industry. This invasive fungal infections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The invasive fungal infections market size has grown steadily in recent years. It will grow from $7.58 billion in 2024 to $7.91 billion in 2025 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to global spread of infections, hematopoietic stem cell transplants, aging population, hospital-acquired infections, environmental factors.
The invasive fungal infections market size is expected to see steady growth in the next few years. It will grow to $9.5 billion in 2029 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to global health preparedness, public health education, novel antifungal agents, climate change impact, multidisciplinary approaches. Major trends in the forecast period include advancements in diagnostic technologies, tailored therapeutic approaches, patient-centric care, combination antifungal therapies, collaborations for drug development.
The forecast of 4.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. hospitals by driving up the cost of echinocandins and amphotericin B formulations sourced from Spain and Israel, exacerbating treatment delays for life-threatening infections and increasing ICU medication costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The projected increase in the population afflicted by Human Immunodeficiency Virus (HIV) is anticipated to propel the expansion of the invasive fungal infection market in the coming years. HIV is a virus that compromises the immune system's ability to combat diseases and infections. As the number of individuals with compromised immune systems, including those affected by HIV or AIDS, rises, susceptibility to invasive fungal infections escalates. This surge creates opportunities for manufacturers to develop and supply specialized and more effective antifungal drugs. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS) in July 2023, the global population living with HIV increased to 39 million in 2022, marking a 3.17% rise from 37.7 million in 2020. Additionally, approximately 1.3 million new HIV infections were reported in 2022. Hence, the anticipated rise in the population affected by HIV is expected to drive the growth of the invasive fungal infection market.
The mounting number of cancer patients is forecasted to fuel the expansion of the invasive fungal infections market in the future. Invasive fungal infections (IFIs) pose severe and potentially life-threatening complications for cancer patients, particularly those with weakened immune systems. The growing population of cancer survivors is a significant factor contributing to the increased risk of IFIs among these individuals. As reported by the National Cancer Institute in November 2022, it is projected that by 2040, there will be approximately 26.0 million cancer survivors. Furthermore, the number of individuals who have survived five or more years after a cancer diagnosis is expected to surge by nearly 30%, reaching 16.3 million over the subsequent decade. Consequently, the escalating number of cancer patients and survivors stands as a driving force behind the growth of the invasive fungal infections market.
Leading companies in the invasive fungal infection market are increasingly focusing on innovative treatments such as Zisavel capsules to enhance therapeutic efficacy, improve patient outcomes, and expand access for individuals affected by serious fungal infections. Zisavel capsules, a generic form of the antifungal isavuconazole, target invasive aspergillosis and mucormycosis-two life-threatening fungal infections. These 100 mg capsules offer a cost-effective alternative, potentially increasing accessibility for patients who require antifungal treatments. For example, in October 2023, BDR Pharmaceuticals, an India-based company specializing in generic and specialty pharmaceuticals, launched Zisavel capsules specifically for treating invasive aspergillosis and mucormycosis. This introduction is expected to reduce treatment costs significantly compared to existing options like voriconazole and posaconazole, making effective antifungal therapy more affordable and accessible.
In August 2023, Sandoz, a Germany-based pharmaceutical company known for its expertise in generic medicines and biosimilars, acquired Astellas Pharma Inc. for an undisclosed amount. This acquisition allows Sandoz to strengthen its portfolio of generics and biosimilars, broaden its market reach, and capitalize on synergies to foster growth and innovation in the pharmaceutical industry. Astellas Pharma Inc., a Japan-based pharmaceutical company, specializes in the research, development, manufacturing, and commercialization of innovative medications. Through this strategic acquisition, Sandoz aims to bolster its position in the global market and advance its offerings across various therapeutic areas.
Major companies operating in the invasive fungal infections market report are Pfizer Inc., Merck And Co. Inc., Bayer AG, Abbott Laboratories, GSK PLC, Gilead Sciences Inc., Siemens Healthineers, Mylan N.V., Astellas Pharma Inc., Quest Diagnostics Incorporated, Sun Pharmaceutical Industries Ltd., BioMerieux SA, BioMarin Pharmaceutical Inc., Xellia Pharmaceuticals, Basilea Pharmaceutica, Cidara Therapeutic Inc., Pulmocide Ltd., NovaBiotics Ltd., F2G Ltd., Giner Inc., Ciron Drugs And Pharmaceuticals Pvt. Ltd., Hexima Limited, Scynexis Inc., Enzon Pharmaceuticals Inc., Matinas BioPharma Holdings Inc., Biosergen AB
North America was the largest region in the invasive fungal infections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the invasive fungal infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the invasive fungal infections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The invasive fungal infections market consists of revenues earned by entities by providing services such as diagnostic testing, clinical research and development, educational programs, and awareness campaign services. The market value includes the value of related goods sold by the service provider or included within the service offering. The invasive fungal infections market also includes sales of azoles, allylamines, and morpholines, which are used in treating invasive fungal infections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Invasive Fungal Infections Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on invasive fungal infections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for invasive fungal infections ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The invasive fungal infections market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Disease Type: Candidemia And Invasive Candidiasis; Intra Abdominal Candidiasis; Cryptococcal Meningitis; Esophageal Candidiasis; Histoplasmosis Acute Pulmonary; Other Disease Type
- 2) By Drug Type: Polyenes; Triazoles; Echinocandins; Flucytosine; Other Drug Type
- 3) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
- Subsegments:
- 1) By Candidemia And Invasive Candidiasis: Bloodstream Infections; Disseminated Candidiasis
- 2) By Intra-Abdominal Candidiasis: Peritoneal Candidiasis; Abscess Formation
- 3) By Cryptococcal Meningitis: Primary Cryptococcal Meningitis; Secondary Cryptococcal Meningitis
- 4) By Esophageal Candidiasis: Acute Esophageal Candidiasis; Chronic Esophageal Candidiasis
- 5) By Histoplasmosis Acute Pulmonary: Disseminated Histoplasmosis; Chronic Pulmonary Histoplasmosis
- 6) By Other Disease Types: Aspergillosis; Mucormycosis; Other Rare Fungal Infections
- Companies Mentioned: Pfizer Inc.; Merck And Co. Inc.; Bayer AG; Abbott Laboratories; GSK plc; Gilead Sciences Inc.; Siemens Healthineers; Mylan N.V.; Astellas Pharma Inc.; Quest Diagnostics Incorporated; Sun Pharmaceutical Industries Ltd.; BioMerieux SA; BioMarin Pharmaceutical Inc.; Xellia Pharmaceuticals; Basilea Pharmaceutica; Cidara Therapeutic Inc.; Pulmocide Ltd.; NovaBiotics Ltd; F2G Ltd.; Giner Inc.; Ciron Drugs And Pharmaceuticals Pvt. Ltd.; Hexima Limited; Scynexis Inc.; Enzon Pharmaceuticals Inc.; Matinas BioPharma Holdings Inc.; Biosergen AB
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Invasive Fungal Infections Market Characteristics
3. Invasive Fungal Infections Market Trends And Strategies
4. Invasive Fungal Infections Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Invasive Fungal Infections Growth Analysis And Strategic Analysis Framework
- 5.1. Global Invasive Fungal Infections PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Invasive Fungal Infections Market Growth Rate Analysis
- 5.4. Global Invasive Fungal Infections Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Invasive Fungal Infections Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Invasive Fungal Infections Total Addressable Market (TAM)
6. Invasive Fungal Infections Market Segmentation
- 6.1. Global Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Candidemia And Invasive Candidiasis
- Intra Abdominal Candidiasis
- Cryptococcal Meningitis
- Esophageal Candidiasis
- Histoplasmosis Acute Pulmonary
- Other Disease Type
- 6.2. Global Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Polyenes
- Triazoles
- Echinocandins
- Flucytosine
- Other Drug Type
- 6.3. Global Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Homecare
- Specialty Clinics
- Other End-Users
- 6.4. Global Invasive Fungal Infections Market, Sub-Segmentation Of Candidemia And Invasive Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bloodstream Infections
- Disseminated Candidiasis
- 6.5. Global Invasive Fungal Infections Market, Sub-Segmentation Of Intra-Abdominal Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Peritoneal Candidiasis
- Abscess Formation
- 6.6. Global Invasive Fungal Infections Market, Sub-Segmentation Of Cryptococcal Meningitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Primary Cryptococcal Meningitis
- Secondary Cryptococcal Meningitis
- 6.7. Global Invasive Fungal Infections Market, Sub-Segmentation Of Esophageal Candidiasis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Acute Esophageal Candidiasis
- Chronic Esophageal Candidiasis
- 6.8. Global Invasive Fungal Infections Market, Sub-Segmentation Of Histoplasmosis Acute Pulmonary, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Disseminated Histoplasmosis
- Chronic Pulmonary Histoplasmosis
- 6.9. Global Invasive Fungal Infections Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Aspergillosis
- Mucormycosis
- Other Rare Fungal Infections
7. Invasive Fungal Infections Market Regional And Country Analysis
- 7.1. Global Invasive Fungal Infections Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Invasive Fungal Infections Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Invasive Fungal Infections Market
- 8.1. Asia-Pacific Invasive Fungal Infections Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Invasive Fungal Infections Market
- 9.1. China Invasive Fungal Infections Market Overview
- 9.2. China Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Invasive Fungal Infections Market
- 10.1. India Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Invasive Fungal Infections Market
- 11.1. Japan Invasive Fungal Infections Market Overview
- 11.2. Japan Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Invasive Fungal Infections Market
- 12.1. Australia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Invasive Fungal Infections Market
- 13.1. Indonesia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Invasive Fungal Infections Market
- 14.1. South Korea Invasive Fungal Infections Market Overview
- 14.2. South Korea Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Invasive Fungal Infections Market
- 15.1. Western Europe Invasive Fungal Infections Market Overview
- 15.2. Western Europe Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Invasive Fungal Infections Market
- 16.1. UK Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Invasive Fungal Infections Market
- 17.1. Germany Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Invasive Fungal Infections Market
- 18.1. France Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Invasive Fungal Infections Market
- 19.1. Italy Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Invasive Fungal Infections Market
- 20.1. Spain Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Invasive Fungal Infections Market
- 21.1. Eastern Europe Invasive Fungal Infections Market Overview
- 21.2. Eastern Europe Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Invasive Fungal Infections Market
- 22.1. Russia Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Invasive Fungal Infections Market
- 23.1. North America Invasive Fungal Infections Market Overview
- 23.2. North America Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Invasive Fungal Infections Market
- 24.1. USA Invasive Fungal Infections Market Overview
- 24.2. USA Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Invasive Fungal Infections Market
- 25.1. Canada Invasive Fungal Infections Market Overview
- 25.2. Canada Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Invasive Fungal Infections Market
- 26.1. South America Invasive Fungal Infections Market Overview
- 26.2. South America Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Invasive Fungal Infections Market
- 27.1. Brazil Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Invasive Fungal Infections Market
- 28.1. Middle East Invasive Fungal Infections Market Overview
- 28.2. Middle East Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Invasive Fungal Infections Market
- 29.1. Africa Invasive Fungal Infections Market Overview
- 29.2. Africa Invasive Fungal Infections Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Invasive Fungal Infections Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Invasive Fungal Infections Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Invasive Fungal Infections Market Competitive Landscape And Company Profiles
- 30.1. Invasive Fungal Infections Market Competitive Landscape
- 30.2. Invasive Fungal Infections Market Company Profiles
- 30.2.1. Alphabet Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
31. Invasive Fungal Infections Market Other Major And Innovative Companies
- 31.1. GSK plc
- 31.2. Gilead Sciences Inc.
- 31.3. Siemens Healthineers
- 31.4. Mylan N.V.
- 31.5. Astellas Pharma Inc.
- 31.6. Quest Diagnostics Incorporated
- 31.7. Sun Pharmaceutical Industries Ltd.
- 31.8. BioMerieux SA
- 31.9. BioMarin Pharmaceutical Inc.
- 31.10. Xellia Pharmaceuticals
- 31.11. Basilea Pharmaceutica
- 31.12. Cidara Therapeutic Inc.
- 31.13. Pulmocide Ltd.
- 31.14. NovaBiotics Ltd
- 31.15. F2G Ltd.
32. Global Invasive Fungal Infections Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Invasive Fungal Infections Market
34. Recent Developments In The Invasive Fungal Infections Market
35. Invasive Fungal Infections Market High Potential Countries, Segments and Strategies
- 35.1 Invasive Fungal Infections Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Invasive Fungal Infections Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Invasive Fungal Infections Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
